Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition

Valerie Byrnes, Anne Miller, Damien Lowry, Erin Hill, Cheryl Weinstein, David Alsop, Robert Lenkinski, Nezam H. Afdhal

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background & Aims: Chronic hepatitis C virus (HCV) infection is associated with altered cerebral metabolism and cognitive dysfunction. We aimed to evaluate the effect of pegylated interferon/ribavirin (PIFN/R) and HCV clearance on cerebral metabolism, and neuropsychological performance. Methods: Fifteen non-cirrhotic HCV positive subjects underwent 1H MR spectroscopy (MRS) before, during, and after treatment with PIFN/R. The metabolites of interest namely, N-acetylaspartate (NAA), choline (Cho), myo-inositol (MI), and the control metabolite creatine (Cr), were acquired from 3 different brain regions; left basal ganglia, left frontal cortex, and left dorso-lateral pre-frontal cortex. Coinciding with this, subjects also underwent a battery of neuropsychological tests to evaluate the domains of verbal learning, memory, attention, language, executive functioning, and motor skills. Seven HCV positive controls (not receiving anti-viral therapy) underwent MRS and neuropsychological testing at two time points, 12 weeks apart, to examine for variation in cerebral metabolites over time and the practice effect of repeat neuropsychological testing. Results: Significant reductions in basal ganglia Cho/Cr (p = 0.03) and basal ganglia MI/Cr (p = 0.03) were observed in sustained virological responders (SVRs, n = 8), but not non-responders/relapsers (NR/R, n = 6), indicative of reduced cerebral infection and/or immune activation in those who cleared virus. SVRs demonstrated significant improvements in verbal learning, memory, and visuo-spatial memory. A small but significant improvement in neurocognitive function secondary to the practice effect was seen in both HCV controls and HCV subjects during treatment. Conclusions: HCV eradication has a beneficial effect on cerebral metabolism and selective aspects of neurocognitive function and is an important factor when contemplating anti-viral therapy in HCV, especially in those with mild disease.

Original languageEnglish (US)
Pages (from-to)549-556
Number of pages8
JournalJournal of Hepatology
Volume56
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Hepacivirus
Cognition
Creatine
Basal Ganglia
Verbal Learning
Frontal Lobe
Inositol
Therapeutics
Choline
Magnetic Resonance Spectroscopy
Motor Skills
Neuropsychological Tests
Ribavirin
Chronic Hepatitis C
Virus Diseases
Interferons
Language
Viruses
Brain
Infection

Keywords

  • Cognitive dysfunction
  • Combination treatment
  • H MRS
  • HCV
  • Hepatitis C
  • Immune activation
  • Metabolite abnormalities
  • Neuropsychological
  • Proton magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Hepatology

Cite this

Byrnes, V., Miller, A., Lowry, D., Hill, E., Weinstein, C., Alsop, D., ... Afdhal, N. H. (2012). Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. Journal of Hepatology, 56(3), 549-556. https://doi.org/10.1016/j.jhep.2011.09.015

Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. / Byrnes, Valerie; Miller, Anne; Lowry, Damien; Hill, Erin; Weinstein, Cheryl; Alsop, David; Lenkinski, Robert; Afdhal, Nezam H.

In: Journal of Hepatology, Vol. 56, No. 3, 03.2012, p. 549-556.

Research output: Contribution to journalArticle

Byrnes, V, Miller, A, Lowry, D, Hill, E, Weinstein, C, Alsop, D, Lenkinski, R & Afdhal, NH 2012, 'Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition', Journal of Hepatology, vol. 56, no. 3, pp. 549-556. https://doi.org/10.1016/j.jhep.2011.09.015
Byrnes, Valerie ; Miller, Anne ; Lowry, Damien ; Hill, Erin ; Weinstein, Cheryl ; Alsop, David ; Lenkinski, Robert ; Afdhal, Nezam H. / Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. In: Journal of Hepatology. 2012 ; Vol. 56, No. 3. pp. 549-556.
@article{12b7ee487f49406f9b8652373ba459fa,
title = "Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition",
abstract = "Background & Aims: Chronic hepatitis C virus (HCV) infection is associated with altered cerebral metabolism and cognitive dysfunction. We aimed to evaluate the effect of pegylated interferon/ribavirin (PIFN/R) and HCV clearance on cerebral metabolism, and neuropsychological performance. Methods: Fifteen non-cirrhotic HCV positive subjects underwent 1H MR spectroscopy (MRS) before, during, and after treatment with PIFN/R. The metabolites of interest namely, N-acetylaspartate (NAA), choline (Cho), myo-inositol (MI), and the control metabolite creatine (Cr), were acquired from 3 different brain regions; left basal ganglia, left frontal cortex, and left dorso-lateral pre-frontal cortex. Coinciding with this, subjects also underwent a battery of neuropsychological tests to evaluate the domains of verbal learning, memory, attention, language, executive functioning, and motor skills. Seven HCV positive controls (not receiving anti-viral therapy) underwent MRS and neuropsychological testing at two time points, 12 weeks apart, to examine for variation in cerebral metabolites over time and the practice effect of repeat neuropsychological testing. Results: Significant reductions in basal ganglia Cho/Cr (p = 0.03) and basal ganglia MI/Cr (p = 0.03) were observed in sustained virological responders (SVRs, n = 8), but not non-responders/relapsers (NR/R, n = 6), indicative of reduced cerebral infection and/or immune activation in those who cleared virus. SVRs demonstrated significant improvements in verbal learning, memory, and visuo-spatial memory. A small but significant improvement in neurocognitive function secondary to the practice effect was seen in both HCV controls and HCV subjects during treatment. Conclusions: HCV eradication has a beneficial effect on cerebral metabolism and selective aspects of neurocognitive function and is an important factor when contemplating anti-viral therapy in HCV, especially in those with mild disease.",
keywords = "Cognitive dysfunction, Combination treatment, H MRS, HCV, Hepatitis C, Immune activation, Metabolite abnormalities, Neuropsychological, Proton magnetic resonance spectroscopy",
author = "Valerie Byrnes and Anne Miller and Damien Lowry and Erin Hill and Cheryl Weinstein and David Alsop and Robert Lenkinski and Afdhal, {Nezam H.}",
year = "2012",
month = "3",
doi = "10.1016/j.jhep.2011.09.015",
language = "English (US)",
volume = "56",
pages = "549--556",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition

AU - Byrnes, Valerie

AU - Miller, Anne

AU - Lowry, Damien

AU - Hill, Erin

AU - Weinstein, Cheryl

AU - Alsop, David

AU - Lenkinski, Robert

AU - Afdhal, Nezam H.

PY - 2012/3

Y1 - 2012/3

N2 - Background & Aims: Chronic hepatitis C virus (HCV) infection is associated with altered cerebral metabolism and cognitive dysfunction. We aimed to evaluate the effect of pegylated interferon/ribavirin (PIFN/R) and HCV clearance on cerebral metabolism, and neuropsychological performance. Methods: Fifteen non-cirrhotic HCV positive subjects underwent 1H MR spectroscopy (MRS) before, during, and after treatment with PIFN/R. The metabolites of interest namely, N-acetylaspartate (NAA), choline (Cho), myo-inositol (MI), and the control metabolite creatine (Cr), were acquired from 3 different brain regions; left basal ganglia, left frontal cortex, and left dorso-lateral pre-frontal cortex. Coinciding with this, subjects also underwent a battery of neuropsychological tests to evaluate the domains of verbal learning, memory, attention, language, executive functioning, and motor skills. Seven HCV positive controls (not receiving anti-viral therapy) underwent MRS and neuropsychological testing at two time points, 12 weeks apart, to examine for variation in cerebral metabolites over time and the practice effect of repeat neuropsychological testing. Results: Significant reductions in basal ganglia Cho/Cr (p = 0.03) and basal ganglia MI/Cr (p = 0.03) were observed in sustained virological responders (SVRs, n = 8), but not non-responders/relapsers (NR/R, n = 6), indicative of reduced cerebral infection and/or immune activation in those who cleared virus. SVRs demonstrated significant improvements in verbal learning, memory, and visuo-spatial memory. A small but significant improvement in neurocognitive function secondary to the practice effect was seen in both HCV controls and HCV subjects during treatment. Conclusions: HCV eradication has a beneficial effect on cerebral metabolism and selective aspects of neurocognitive function and is an important factor when contemplating anti-viral therapy in HCV, especially in those with mild disease.

AB - Background & Aims: Chronic hepatitis C virus (HCV) infection is associated with altered cerebral metabolism and cognitive dysfunction. We aimed to evaluate the effect of pegylated interferon/ribavirin (PIFN/R) and HCV clearance on cerebral metabolism, and neuropsychological performance. Methods: Fifteen non-cirrhotic HCV positive subjects underwent 1H MR spectroscopy (MRS) before, during, and after treatment with PIFN/R. The metabolites of interest namely, N-acetylaspartate (NAA), choline (Cho), myo-inositol (MI), and the control metabolite creatine (Cr), were acquired from 3 different brain regions; left basal ganglia, left frontal cortex, and left dorso-lateral pre-frontal cortex. Coinciding with this, subjects also underwent a battery of neuropsychological tests to evaluate the domains of verbal learning, memory, attention, language, executive functioning, and motor skills. Seven HCV positive controls (not receiving anti-viral therapy) underwent MRS and neuropsychological testing at two time points, 12 weeks apart, to examine for variation in cerebral metabolites over time and the practice effect of repeat neuropsychological testing. Results: Significant reductions in basal ganglia Cho/Cr (p = 0.03) and basal ganglia MI/Cr (p = 0.03) were observed in sustained virological responders (SVRs, n = 8), but not non-responders/relapsers (NR/R, n = 6), indicative of reduced cerebral infection and/or immune activation in those who cleared virus. SVRs demonstrated significant improvements in verbal learning, memory, and visuo-spatial memory. A small but significant improvement in neurocognitive function secondary to the practice effect was seen in both HCV controls and HCV subjects during treatment. Conclusions: HCV eradication has a beneficial effect on cerebral metabolism and selective aspects of neurocognitive function and is an important factor when contemplating anti-viral therapy in HCV, especially in those with mild disease.

KW - Cognitive dysfunction

KW - Combination treatment

KW - H MRS

KW - HCV

KW - Hepatitis C

KW - Immune activation

KW - Metabolite abnormalities

KW - Neuropsychological

KW - Proton magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=84857363977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857363977&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2011.09.015

DO - 10.1016/j.jhep.2011.09.015

M3 - Article

C2 - 22027578

AN - SCOPUS:84857363977

VL - 56

SP - 549

EP - 556

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 3

ER -